Main container

The METROPHOLYS Study Metronomic Cyclophosphamide vs Doxorubicinin Elderly Patients with Advanced Soft Tissue Sarcomas Randomized, Controlled Open Label Clinical Trial

Title
The METROPHOLYS Study Metronomic Cyclophosphamide vs Doxorubicinin Elderly Patients with Advanced Soft Tissue Sarcomas Randomized, Controlled Open Label Clinical Trial
Code
IOV-2018-STS-METROPHOLYS
Type
Sperimentale
Start Year
2019
Status
In Corso

Principal Investigator

Description

Studio clinico no profit di Fase 3, multicentrico, randomizzato, in aperto in pazienti anziani con Sarcoma dei Tessuti molli in stadio avanzato.

Tutti i medici oncologi dell'Osteoncologia sono co-investigator e quindi arruolano pazienti per questo studio.

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
06/07/2022 13:15